2025-03-31-accounts - Head & Neck Cancer and Rhinology Trust

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

Trustees' Annual Report for the period

Period start date Period end date Day Month Year Day Month Year 01 04 2024 To 31 03 2025

From

Section A Reference and administration details

Charity name Other names charity is known by Registered charity number (if any) 1180082

The Head and Neck Cancer Research Trust

Charity's principal address c/o 4[th] Floor, Eldon Chambers 30-32 Fleet Street London Postcode EC4Y 1AA

Names of the charity trustees who manage the charity

Trustee name	Office (if any)	Dates acted if not for whole year
Karen Wint	Chair
Dr Amie Mertens	Trustee
Dr Vessela Vassileva	Trustee	01/04/2024 – 04/12/2024

Names of the trustees for the charity, if any, (for example, any custodian trustees)

Name Dates acted if not for whole year

March 2012

TAR

Names and addresses of advisers (Optional information)

Names and addresses of advisers (Optional information)	Names and addresses of advisers (Optional information)	Names and addresses of advisers (Optional information)
Type of adviser Name Address
Accountant	Kershen Fairfax Ltd	4thFloor, Eldon Chambers, 30-32 Fleet Street, London, EC4Y 1AA

Name of chief executive or names of senior staff members (Optional information)

Section B Structure, governance and management

Description of the charity’s trusts

Constitution Type of governing document (eg. trust deed, constitution) CIO How the charity is constituted

(eg. trust, association, company)

Appointed Trustee selection methods

(eg. appointed by, elected by)

Additional governance issues (Optional information)

You may choose to include additional information, where relevant, about:

policies and procedures adopted for the induction and training of trustees;
the charity’s organisational structure and any wider network with which the charity works;
relationship with any related parties;
trustees’ consideration of major risks and the system and procedures to manage them.

Section C Objectives and activities

Summary of the objects of the charity set out in its governing document

FOR THE PUBLIC BENEFIT THE RELIEF OF SICKNESS AND THE PROMOTION AND PROTECTION OF GOOD HEALTH BY THE ADVANCEMENT OF RESEARCH INTO PREVENTION, EARLY DETECTION AND TREATMENT OF HUMAN PAPILLOMAVIRUS (HPV)-ASSOCIATED HEAD AND NECK CANCER AND OTHER HEAD AND NECK CANCERS BY THE PROVISION OF RESEARCH GRANTS AND TO DISSEMINATE THE USEFUL RESULTS OF SUCH RESEARCH.

March 2012

TAR

Host of the annual EUSICA/INSICA international meeting in May 2025, in collaboration with Oncology Professional Care. A two day interdisciplinary clinical and research meeting bringing together the top researchers and clinicians/ surgeons from across the world in the field of rare head and neck tumours, sinonasal cancers and brain tumours. Running alongside this was a skull base surgery skill course for surgical trainees.

Research Grants awarded to Professor M. Lechner, Honorary Research Fellows and a PhD student from the Division of Surgery and Interventional Science, UCL cancer institute. In particular for Summary of the main their work in translational research on sinonasal cancers and HPV activities undertaken for the associated oropharyngeal cancer, with the aim of improving public benefit in relation to prevention, early detection and treatment. these objects (include within this section the statutory Development and expansion of the HNCR Trust Instagram account. declaration that trustees have Led voluntarily by a Medical Doctor. had regard to the guidance issued by the Charity Continued membership of the NCVO. Commission on public benefit) The Trustees have supported events and activities in regard to the

The Trustees have supported events and activities in regard to the guidance issued by the Charity Commission on public benefit (PB1).

Additional details of objectives and activities (Optional information)

You may choose to include further statements, where relevant, about:

policy on grantmaking;
policy programme related investment;
contribution made by volunteers.

March 2012

TAR

Section D Achievements and performance

Summary of the main achievements of the charity during the year

The charity has had its largest income during the tax year 24/25, since its establishment in 2018. This is due to hosting the EUSICA/INSICA-Brain conference in collaboration with Oncology Professional Care. Conference sponsorship and ticket sales provided the main charity income for this tax year. This money was used primarily in organising the conference and was a one-off opportunity for the charity. The unique opportunity as Trustees, to be involved with such a large international event provided valuable experience in event management for the future.

The usual income of the charity comes from Donations from individuals and other charities. This money was partly used to fund research projects in the field of head and neck cancers. The cash funds remaining in the account are used for payments such as the website, accountant and insurance.

This year the Trustees were able to donate the most funds the charity has ever had the capacity to do. The cash funds at the end of the year are also the highest remaining and the Trustees look forward to being able to support further research projects and public awareness programmes in the following tax year.

March 2012

TAR

Section E Financial review

Brief statement of the

charity’s policy on reserves

The charity has no specific policy on reserves as income each year is neither regular nor known in advance. As such funds will only be spent if there are sufficient cash reserves.

Details of any funds materially in deficit

Further financial review details (Optional information)

You may choose to include additional information, where relevant about:

the charity’s principal sources of funds (including any fundraising);
how expenditure has supported the key objectives of the charity;
investment policy and objectives including any ethical investment policy adopted.

Section F Other optional information

Section G Declaration

The trustees declare that they have approved the trustees’ report above.

Signed on behalf of the charity’s trustees

Signature(s)

----- Start of picture text -----
|| |---| |A Mertens|

----- End of picture text -----

Full name(s) Dr A Mertens Position (eg Secretary, Chair, Trustee etc) Date 22/09/2025

March 2012

TAR

The Head and Neck Cancer Research Trust No (if any) 1180082 Receipts and payments accounts CC16a For the period Period start date Period end date To from 01/04/2024 31/03/2025

Section A Receipts and payments

A1 Receipts	Unrestricted funds to the nearest £ 4,438 17,000 13,921 - - - - - 35,359 - - - 35,359	Restricted funds to the nearest £ - - - - - - - - - - - - -	Endowment funds to the nearest £ - - - - - - - - - - - - -	Total funds to the nearest £ 4,438 17,000 13,921 - - - - - 35,359 - - - 35,359 696 17,804 24,955 3,328 60 50 420 1,407 48,720 - - - 48,720 - 13,361	Last year to the nearest £
Donations	4,438				23,032
Conference sponsorship	17,000				-
Conference ticket sales	13,921				-
	-				-
	-				-
	-				-
	-				-
	-				-
*Sub total*(Gross income for AR)	35,359				23,032

A2 Asset and investment sales, (see table).
	-
	-				-
*Sub total*	-				-
*Total receipts* A3 Payments
					23,032

Computer costs	696	-	-	696	1,025
Conference expenses	17,804	-	-	17,804	508
Post conference expenses	24,955	-	-	24,955
Researchgrants	3,328	-	-	3,328	4,000
Sponsorshipcosts	60	-	-	60	786
Advertisingcosts	50	-	-	50	200
Accountancyfees	420	-	-	420	300
Other expenses	1,407	-	-	1,407	107
**Sub total **	48,720	-	-	48,720	6,926

A4 Asset and investment purchases, (see table)
	-
	-
**Sub total **	-				-
*Total payments* *Net of receipts/(payments)* A5 Transfers between funds A6 Cash funds last year end *Cash funds this year end*
					6,926

	- 13,361			- 13,361	16,106
	-			-	-
	17,365			17,365	1,259
	4,004			4,004	17,365

CCXX R1 accounts (SS)

22/09/2025

Section B Statement of assets and liabilities at the end of the period

Details Details *Total cash funds* (agree balances with receipts and payments account(s)) NatWest bank account Details Details Details Signature A Mertens	Unrestricted funds Restricted funds to nearest £ to nearest £ 4,004 - - - - - 4,004 - OK OK Unrestricted funds Restricted funds to nearest £ to nearest £ - - - - - - - - - - - - Fund to which asset belongs Cost (optional) - - - - - Fund to which asset belongs Cost (optional) - - - - - - - - - Fund to which liability relates Amount due (optional) - - - - - Print Name A Mertens	Endowment funds to nearest £
		-
		-
		-
		-
		OK
		Endowment funds to nearest £
		-
		-
		-
		-
		-
		-
		Current value (optional)
		-
		-
		-
		-
		-
		Current value (optional)
		-
		-
		-
		-
		-
		-
		-
		-
		-
		When due (optional)






		Date of approval
A Mertens	A Mertens	22.09.25

CCXX R2 accounts (SS)

22/09/2025

Independent examiner's report on the accounts

Section A Independent Examiner’s Report

Report to the trustees/ Charity Name The Head and Neck Cancer Research Trust members of On accounts for the year 31[st] March 2025 Charity no 1180082 ended (if any) Set out on pages 1-2 (remember to include the page numbers of additional sheets)

I report to the trustees on my examination of the accounts of the above charity (“the Trust”) for the year ended 31/03/2025.

Responsibilities and As the charity trustees of the Trust, you are responsible for the preparation basis of report of the accounts in accordance with the requirements of the Charities Act 2011 (“the Act”).

I report in respect of my examination of the Trust’s accounts carried out under section 145 of the 2011 Act and in carrying out my examination, I have followed the applicable Directions given by the Charity Commission under section 145(5)(b) of the Act.

Independent I have completed my examination. I confirm that no material matters have examiner's statement come to my attention (other than that disclosed below *) in connection with the examination which gives me cause to believe that in, any material respect:

accounting records were not kept in accordance with section 130 of the Act or
the accounts do not accord with the accounting records

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in order to enable a proper understanding of the accounts to be reached.

Please delete the words in the brackets if they do not apply.

Date: 22/09/2025 Signed: Name: M D Cox Relevant professional ACA FCCA qualification(s) or body (if any): Address: c/o Kershen Fairfax Ltd, 4[th] Floor, Eldon Chambers 30-32 Fleet Street, London EC4Y 1AA

October 2018

IER

Section B Disclosure

Only complete if the examiner needs to highlight matters of concern (see CC32, Independent examination of charity accounts: directions and guidance for examiners).

Give here brief details of any items that the examiner wishes to disclose .

October 2018

IER